出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/01/08 15:58:31」(JST)
CD70 molecule | |
---|---|
Identifiers | |
Symbol | CD70 |
Alt. symbols | CD27LG, TNFSF7 |
Entrez | 970 |
HUGO | 11937 |
OMIM | 602840 |
RefSeq | NM_001252 |
UniProt | P32970 |
Other data | |
Locus | Chr. 19 p13 |
CD70 (Cluster of Differentiation 70) is a ligand for CD27.
The CD70 protein is expressed on highly activated lymphocytes (like in T- and B-cell lymphomas). It is therefore suggested that anti-CD70 antibodies might be a possible treatment for CD70 positive lymphomas as normal lymphocytes do not express a lot of CD70.[1]
ARGX-110 is a CD70-specific antibody that is currently under investigation for the treatment of hematological malignancies. It is being developed by the Belgian company arGEN-X. In December 2013 a first part of a phase 1b trial was completed. In January 2014 a safety and efficacy phase of the study started.[2]
Vorsetuzumab mafodotin is a CD70-targeted antibody-drug conjugate that started clinical trials for renal cell carcinoma.[3]
|
|
|
This membrane protein–related article is a stub. You can help Wikipedia by expanding it.
|
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
リンク元 | 「表面抗原分類」「CD27」 |
関連記事 | 「CD」 |
CD1 | CD21 | CD41 | CD61 | CD81 |
CD2 | CD22 | CD42 | CD62 | CD82 |
CD3 | CD23 | CD43 | CD63 | CD83 |
CD4 | CD24 | CD44 | CD64 | CD84 |
CD5 | CD25 | CD45 | CD65 | CD85 |
CD6 | CD26 | CD46 | CD66 | CD86 |
CD7 | CD27 | CD47 | CD67 | CD87 |
CD8 | CD28 | CD48 | CD68 | CD88 |
CD9 | CD29 | CD49 | CD69 | CD89 |
CD10 | CD30 | CD50 | CD70 | CD90 |
CD11 | CD31 | CD51 | CD71 | CD91 |
CD12 | CD32 | CD52 | CD72 | CD92 |
CD13 | CD33 | CD53 | CD73 | CD93 |
CD14 | CD34 | CD54 | CD74 | CD94 |
CD15 | CD35 | CD55 | CD75 | CD95 |
CD16 | CD36 | CD56 | CD76 | CD96 |
CD17 | CD37 | CD57 | CD77 | CD97 |
CD18 | CD38 | CD58 | CD78 | CD98 |
CD19 | CD39 | CD59 | CD79 | CD99 |
CD20 | CD40 | CD60 | CD80 | CD100 |
.